Skip to content

Helping Newborns with Jaundice: Comparing the Old and New AAP Treatment Charts

Evaluation of Midazolam, Ketamine, and Dexmedetomidine for Pediatric Premedication Prior to Radiological Imaging: A Comparative Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090837
Enrollment
550
Registered
2025-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P599- Neonatal jaundice, unspecified

Interventions

Intervention1: PHOTOTHERAPY: BABIES WHOSE BILIRUBIN VALUES THAT IS TAKEN AFTER 48 HOURS OF LIFE ARE ABOVE THE CUT OFF OF OLD CHART FOR GROUP A AND NEW CHART FOR GROUP B ARE STARTED WITH PHOTOTHERAPY C

Sponsors

DR REXINA DARTHY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newborn babies more than or equal to 35 weeks of gestation age with neonatal hyperbilirubinemia.

Exclusion criteria

Exclusion criteria: Any newborn having major congenital malformations is excluded, Parents denying consent, SGA babies with Birth weight less than 3rd as per Fenton Chart.

Design outcomes

Primary

MeasureTime frame
To compare Rebound jaundice bilirubin level post-discontinuation of phototherapy that is taken 24hours after stopping phototherapy requiring re-initiation of phototherapy within 4 weeksTimepoint: To compare Rebound jaundice bilirubin level post-discontinuation of phototherapy that is taken 24hours after stopping phototherapy requiring re-initiation of phototherapy within in 4 weeks

Secondary

MeasureTime frame
1.To Compare the need for phototherapy 2.Duration of phototherapy 3.Requirement of readmission for phototherapy 4.Need for sampling to measure the bilirubin levels 5.Need for exchange transfusion Timepoint: within 4 weeks

Countries

India

Contacts

Public ContactDR GIRIDHAR

CHETTINA HOSPITAL AND RESEARCH INSTITUTE

giridharsethu@gmail.com9841027228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026